A Biological Gamechanger in Cancer Immunotherapy

We hosted a visit of the Minister of Economics, Stephanie Lose, and the Frederiksberg Mayor candidate, Jan E. Jørgensen. They were here in Symbion to hear about the main source of value creation in Denmark (potentially "the next Novo") and the future cure for cancer.

TEAM NEWS: After a successful preclinical test, which brings us one step closer to curing cancer, we have expanded our staff with Linh Trinh and Caspar Skovbo Christensen

We have finished the first pre-clinical trials with interesting data from the lab (human blood samples and our test vaccine). Now it is time to start animal trials. One step closer to curing (some major) cancers.

We have just started our pre-clinical tests, that will show if the immune system has a response that under special conditions that we create will kill the cancer. To the right is Linh (in charge of the trial), to the left is Caroline.

Curing cancer (?) Soon we will start pre-clinical testing to see if we are right in our assumption on how the immune system functions - so that we can harness it to kill cancer. In the picture are (from left to right): Linh (who is responsible for the tests carried out by Hervolution), Kaare (CEO of Catavax), Peter (Founder of Hervolution), and Christian (chairman of Catavax)

We have founded Catavax A/S in DK and US. Capital raised, patent applications submitted, pre-clinical trials started. We wish to find one or a significant part of a cure for cancer, utilizing the immune system.